Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients

作者: Lawrence E Harrison , Jose G Guillem , Philip Paty , Alfred M Cohen

DOI: 10.1016/S1072-7515(97)00012-4

关键词:

摘要: Abstract Background: Although prospective trials have demonstrated that postoperative chemotherapy for nodepositive colon cancer patients provides survival benefit, no improvement in has been documented node-negative patients. There are, however, a subset of go on to die their disease. We hypothesize this may benefit from chemotherapy. analyzed large cohort nodenegative single institution determine prognostic factors predict which with might experience recurrence and can Study Design: A review the database colorectal at Memorial Sloan-Kettering Cancer Center (MSKCC) between 1985 1993 identified 572 who underwent curative resection (T 1,2,3,4 N 0 M ). Demographic, serum, pathologic were significance. Survival was calculated by method Kaplan-Meier compared log rank test. Multivariate analysis Cox proportional hazard model. Results: Median follow-up 35 months. Factors predictive univariate include tumor stage, overall preoperative serum carcinoembryonic antigen (CEA) elevation. By multivariate analysis, stage CEA level predicted survival. Conclusions: Routine histologic demographic do not outcome Preoperative analysis. elevation identifies group poor prognosis defines

参考文章(17)
Guido Francini, Roberto Petrioli, Luciano Lorenzini, Sergio Mancini, Salvatore Armenio, Gabriello Tanzini, Stefania Marsili, Antonietta Aquino, Giuseppe Marzocca, Serenella Civitelli, Lorenzo Mariani, Domenico De Sando, Sergio Bovenga, Marco Lorenzi, Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer Gastroenterology. ,vol. 106, pp. 899- 906 ,(1994) , 10.1016/0016-5085(94)90748-X
C G Moertel, T R Fleming, J S Macdonald, D G Haller, J A Laurie, C M Tangen, J S Ungerleider, W A Emerson, D C Tormey, J H Glick, Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. Journal of Clinical Oncology. ,vol. 13, pp. 2936- 2943 ,(1995) , 10.1200/JCO.1995.13.12.2936
ROBERT GOSLIN, GLENN STEELE, JOHN MACINTYRE, ROBERT MAYER, PAUL SUGARBAKER, KATHRYN CLEGHORN, RICHARD WILSON, NORMAN ZAMCHECK, The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Annals of Surgery. ,vol. 192, pp. 747- 751 ,(1980) , 10.1097/00000658-198012000-00010
Scott E Kern, Eric R Fearon, Kasper WF Tersmette, John P Enterline, Mark Leppert, Yusuke Nakamura, Ray White, Bert Vogelstein, Stanley R Hamilton, Allelic Loss in Colorectal Carcinoma JAMA: The Journal of the American Medical Association. ,vol. 261, pp. 3099- 3103 ,(1989) , 10.1001/JAMA.1989.03420210047014
Harold J. Wanebo, Bhaskar Rao, Carl M. Pinsky, Raymond G. Hoffman, Maus Stearns, Morton K. Schwartz, Herbert F. Oettgen, Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer The New England Journal of Medicine. ,vol. 299, pp. 448- 451 ,(1978) , 10.1056/NEJM197808312990904
GLENN STEELE, SUSAN ELLENBERG, KENNETH RAMMING, MICHAEL OʼCONNELL, CHARLES MOERTEL, HOWARD LESSNER, HOWARD BRUCKNER, JOHN HORTON, PHILLIP SCHEIN, NORMAN ZAMCHECK, JOEL NOVAK, E. DOUGLAS HOLYOKE, CEA Monitoring Among Patients in Multi-institutional Adjuvant G.I. Therapy Protocols Annals of Surgery. ,vol. 196, pp. 162- 169 ,(1982) , 10.1097/00000658-198208000-00008
Thomas E. Witzig, Charles L. Loprinzi, Nick J. Gonchoroff, Herbert M. Reiman, Steven S. Cha, H. Sam Wieand, Jerry A. Katzmann, J. Kevin Paulsen, Charles G. Moertel, DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer. ,vol. 68, pp. 879- 888 ,(1991) , 10.1002/1097-0142(19910815)68:4<879::AID-CNCR2820680434>3.0.CO;2-4
Charles G Moertel, Judith R O'Fallon, Vay LW Go, Michael J O'Connell, Grenville S Thynne, None, The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer. ,vol. 58, pp. 603- 610 ,(1986) , 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K
S. F. Sener, J. P. Imperato, J. Chmiel, A. Fremgen, J. Sylvester, The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. CA: A Cancer Journal for Clinicians. ,vol. 39, pp. 50- 57 ,(1989) , 10.3322/CANJCLIN.39.1.50